Skip to main content
. Author manuscript; available in PMC: 2018 Oct 29.
Published in final edited form as: Adv Inorg Chem. 2015 Nov 16;68:1–41. doi: 10.1016/bs.adioch.2015.09.001

Figure 2.

Figure 2

Established “core complexes” of technetium with well-defined structure and high stability, used in current approaches to the design of 99mTc radiopharmaceuticals. X represents a linker group for bioconjugation.